PayaVax G79

PayaVax G79 is an innovative inactivated vaccine designed as a bivalent solution to protect poultry against Newcastle Disease Genotype VII (GVII) and Avian Influenza H9N2. This vaccine is developed from local virus strains and produced in accordance with international standards, including GMP (Good Manufacturing Practices) principles. The first bivalent vaccine produced in Iran Effectively stimulates the immune system Long-lasting immunity Produced according to global standards Approved by the Iranian Veterinary Organization

Indications

PayaVax G79 is indicated for the immunization of poultry (broilers, breeders, and layers) against:

Newcastle Disease caused by Genotype GVII
Avian Influenza caused by H9N2 virus

Dosage and Administration

For birds under 3 weeks of age: 0.2 mL per bird via subcutaneous injection
For birds over 3 weeks of age: 0.5 mL per bird via intramuscular or subcutaneous injection

Instructions for Use

Remove the vaccine vial from the refrigerator and allow it to reach room temperature.
Carefully read and follow the provided instructions.
Shake the vial thoroughly several times to ensure a homogeneous suspension, then draw the vaccine into the syringe.

Active Ingredients

Newcastle Disease Virus (NDV-GVII): 10⁸ EID₅₀ / Dose
Avian Influenza Virus H9N2: 10⁸ EID₅₀ / Dose

Sterile Injection Protocol

Always use sterile equipment for injection to prevent contamination during the vaccination process.

Injection Methods

Subcutaneous injection: Administer in the lower neck area. Insert the needle under the skin and direct it straight toward the neck.
Intramuscular injection: Inject into the breast muscle at a 45-degree angle to avoid penetrating the abdominal cavity.

Storage Conditions

Store at 2–8°C
Keep the product away from light

Packaging

500 mL bottle containing 2,500 doses

PayaVax G79